Avet-Loiseau, Hervé <br/><br/>
Minimal Residual Disease Status as a Surrogate Endpoint for Progression-free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  01 2020 
 - e30-e37 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.1016/j.clml.2019.09.622  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Multiple Myeloma--complications<br/>Neoplasm, Residual--etiology<br/>Progression-Free Survival